Skip to main content
. 2016 Jun 14;7(26):39332–39344. doi: 10.18632/oncotarget.10045

Table 3. Multiple regression analysis of serum TG and pituitary hormones in the study.

Variables TG (mmol/L)
B SE 95% CI of B Beta p value
LogTSH (mIU/L) 0.045 0.018 0.010, 0.081 0.260 0.013
FSH (mIU/mL) 0.561 0.205 0.154, 0.967 0.280 0.007
LH (mIU/mL) 0.394 0.135 0.127, 0.662 0.298 0.004
ACTH (pg/mL) −1.240 0.493 −2.219, −0.260 −0.251 0.014

Data are B (unstandardized coefficients), SE (corresponding standard error), 95% CI of B, Beta (standardized coefficients) and p value

for linear regression analysis of TG.

Abbreviations: TG, Triglyceride; TSH, thyroid-stimulating hormone; FSH, follicle-stimulating hormone; LH, luteinizing hormone;

ACTH, adrenocorticotropin; FT3, free triiodothyronine; FT4, free thyroxine; T, testosterone; COR, cortisol.

Values shown were adjusted for Age, BMI, FPG, SBP and corresponding target gland hormones (LogTSH was adjusted for FT3 and FT4; both FSH and LH were adjusted for T; ACTH was adjusted for COR).

TSH was transformed to its natural logarithm to optimize the models. A value of p < 0.05 was considered statistically significant.